AI assistant
Sending…
ACADIA PHARMACEUTICALS INC — Director's Dealing 2015
Jun 3, 2015
31237_dirs_2015-06-03_4db1fb11-5ffe-40dc-a9a3-31205d843f38.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2015-06-01
Reporting Person: Iversen Leslie L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-01 | Common Stock | M | 6500 | $8.85 | Acquired | 20000 | Direct |
| 2015-06-01 | Common Stock | M | 7627 | $8.85 | Acquired | 27627 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-01 | Stock option (right to buy) | $8.85 | M | 6500 | Disposed | 2015-06-09 | Common Stock (6500) | Direct |
| 2015-06-01 | Stock option (right to buy) | $8.85 | M | 7627 | Disposed | 2015-06-09 | Common Stock (7627) | Direct |
Footnotes
F1: 25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following June 10, 2005.
More from ACADIA PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20